Call for an instant quote
0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
04 June 2015 09:32
Scientists have hailed the potential of the new drug
A new drug could help patients with a devastating form of lung cancer to live longer, it has been suggested.
Nivolumab, an immuno-therapy drug that unshackles the immune system so it can attack cancerous cells, has been shown to double the life expectancy of genetically targeted patients with advanced non-squamous non-small cell lung cancer.
One expert has described the results of the major international trial as a "paradigm shift" in the battle against lung cancer.
Lung cancer is one of the UK's most serious forms of the disease.
Advanced non-squamous non-small cell lung cancer accounts for around 85% of all cases of the lung disease, which is diagnosed in 43,463 new patients and is responsible for 35,371 deaths each year in the UK.
Like other cancers, treatment depends on how far it has spread and how good your general health is.
But whether you are a cancer survivor or are undergoing treatment, cancer travel insurance means you can still enjoy jetting off to sunnier climes around the world with family and friends.
Policies can include cover for replacing lost medication and access to 24/7 emergency assistance.
Longer life expectancy
The new research, led by Dr Luis Paz-Ares, from the Hospital Universitario Virgen Del Rocio in Spain, compared the effectiveness of nivolumab and the standard chemotherapy drug docetaxel in 582 patients with advanced non-squamous non-small cell lung cancer.
Nivolumab reduced the risk of dying by 27% compared with docetaxel and increased typical survival time from 9.4 to 12.2 months.
In patients whose cancers produced higher levels of a tumour protein called PD-L1, survival time more than doubled from eight to 19.4 months.
Dr David Chao, consultant medical oncologist at the Royal Free Hospital in London, described the findings as a paradigm shift in the treatment of lung cancer.
22 March 2017
Mountaineers looking to scale the world's highest peak may need to shell out for a GPS device, according to Nepal's tourism chief.
21 March 2017
The effects of being in skyscrapers, at concerts or even walking on wobbly bridges could help scientists understand the experiences of dementia sufferers, researchers are claiming.
18 March 2017
A young actor has released pictures of a lump on her throat that turned out to be thyroid cancer, with hopes the image will raise awareness and alert others who may be suffering from the disease.
17 March 2017
A "promising treatment" for aggressive blood cancer needs more evidence of its effectiveness before NHS doctors will be able to prescribe, a watchdog is warning.
16 March 2017
Millions of Brits are opting for coach holidays over jet-setting and cruises, new research indicates.
15 March 2017
Thousands of flights to and from America's north east have been cancelled in preparation for a "life-threatening" storm poised to hit the country.
14 March 2017
Seniors who experience weight loss should not put it down to the normal ageing process, experts are warning.
11 March 2017
Gatwick Airport is insisting it is still a "credible and deliverable" expansion option, as the airport experienced its busiest ever February.
08 March 2017
Strikes by French air traffic controllers (ATCs) are leading to delays and cancellations across the UK.
10 March 2017
Waiting times for kidney transplant patients have fallen significantly, health officials have said.
09 March 2017
A Dutch snowboarder has been fatally injured in the second avalanche to hit the French Alps in 24 hours.
07 March 2017
The risk of developing a deadly form of breast cancer can be cut by 40% by following a Mediterranean diet, new research has found.